Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy

Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy

AimTo evaluate the feasibility of computed tomography (CT) - derived measurements of body composition parameters to predict the risk factor of non-objective response (non-OR) in patients with hepatocellular carcinoma (HCC) undergoing anti-PD-1 immunotherapy and hepatic artery infusion chemotherapy (...

Full description

Bibliographic Details
Main Authors: Xiaoping Yi, Yan Fu, Qianyan Long, Yazhuo Zhao, Sai Li, Chunhui Zhou, Huashan Lin, Xiaolian Liu, Chang Liu, Changyong Chen, Liangrong Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
myosteatosis
predictor
treatment response
hepatocellular carcinoma
hepatic artery infusion chemotherapy
anti-PD-1 immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.892192/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.892192/full

Similar Items